# Pharmaceuticals Sector Canonical URL: https://biopharmsignal.com/sector/pharmaceuticals Pharmaceuticals is a company sector tag on BioPharmSignal. This page groups public biotech and healthcare companies associated with Pharmaceuticals, making it easier to scan related businesses, compare peers, and follow companies exposed to the same modality, disease area, or development theme. Companies currently grouped under Pharmaceuticals: 81 ## Recent Sector News - 2026-07-20 07:00 EST — GSK — [European Medicines Agency accepts submission to update Bexsero label for 1-dose Meningitis B booster in 10+ year olds](https://biopharmsignal.com/news/GSK/european-medicines-agency-accepts-submission-to-update-bexsero-label-for-1-dose--8906d096) — Source: GSK plc - 2026-07-17 09:00 EST — GSK — [GSK provides an update on CALM-1 and CALM-2 phase III trials for camlipixant in refractory chronic cough (RCC)](https://biopharmsignal.com/news/GSK/gsk-provides-an-update-on-calm-1-and-calm-2-phase-iii-trials-for-camlipixant-in--0e112206) — Source: GSK plc - 2026-07-15 13:40 EST — GSK — [GSK completes acquisition of Nuvalent, Inc.](https://biopharmsignal.com/news/GSK/gsk-completes-acquisition-of-nuvalent-inc-c44954f4) — Source: GSK plc - 2026-07-14 20:03 EST — VANI — [Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026](https://biopharmsignal.com/news/VANI/vivani-medical-to-present-at-the-emerging-growth-conference-on-july-15-2026-793033b6) — Source: Vivani Medical - 2026-07-14 12:32 EST — ICCM — [IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation](https://biopharmsignal.com/news/ICCM/icecure-expands-u-s-commercial-team-to-meet-surging-demand-for-prosense-cryoabla-7980c317) — Source: IceCure Medical - 2026-07-14 12:00 EST — IKT — [Inhibikase Therapeutics Announces Sale of $50 Million of Shares Through its At-the-Market (ATM) Facility](https://biopharmsignal.com/news/IKT/inhibikase-therapeutics-announces-sale-of-50-million-of-shares-through-its-at-th-30edf4cb) — Source: Inhibikase Therapeutics - 2026-07-14 08:00 EST — ACXP — [Acurx Pharmaceuticals Announces Scientific Poster Presentation of Ibezapolstat's Microbiome Preservation Data in Multiply-recurrent C. difficile Infection](https://biopharmsignal.com/news/ACXP/acurx-pharmaceuticals-announces-scientific-poster-presentation-of-ibezapolstat-s-7d80a5a2) — Source: Acurx Pharmaceuticals - 2026-07-13 12:01 EST — AEMD — [Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier®](https://biopharmsignal.com/news/AEMD/aethlon-medical-continues-to-observe-directional-changes-in-second-cohort-of-aus-9cc3f8f7) — Source: Aethlon Medical - 2026-07-13 07:00 EST — GSK — [Jemperli (dostarlimab) achieves sustained clinical complete responses in dMMR/MSI-H locally advanced rectal cancer](https://biopharmsignal.com/news/GSK/jemperli-dostarlimab-achieves-sustained-clinical-complete-responses-in-dmmr-msi--18610cf7) — Source: GSK plc - 2026-07-10 12:04 EST — SEM — [Select Medical Holdings Corporation to be Acquired by Consortium Led by Robert A. Ortenzio, Martin F. Jackson and WCAS | Select Medical](https://biopharmsignal.com/news/SEM/select-medical-holdings-corporation-to-be-acquired-by-consortium-led-by-robert-a-1855a81b) — Source: Select Medical - 2026-07-10 11:00 EST — GSK — [GSK’s licensor Hansoh Pharma announces positive phase III results for Ris-Rez in China patient population](https://biopharmsignal.com/news/GSK/gsk-s-licensor-hansoh-pharma-announces-positive-phase-iii-results-for-ris-rez-in-b379a2b1) — Source: GSK plc - 2026-07-09 10:00 EST — GSK — [Roy Jakobs to join GSK Board as Non-Executive Director](https://biopharmsignal.com/news/GSK/roy-jakobs-to-join-gsk-board-as-non-executive-director-560f2019) — Source: GSK plc - 2026-07-08 08:00 EST — ACXP — [Acurx Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 14, 2026 Conference Call and Provide Business Update](https://biopharmsignal.com/news/ACXP/acurx-pharmaceuticals-to-discuss-second-quarter-2026-financial-results-on-august-1f2a139a) — Source: Acurx Pharmaceuticals - 2026-07-07 11:35 EST — VANI — [Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management](https://biopharmsignal.com/news/VANI/vivani-medical-enters-into-agreement-with-novo-nordisk-to-evaluate-npm-139-a-min-9e9275ac) — Source: Vivani Medical - 2026-07-06 13:30 EST — CRIS — [Curis Consents First Six Patients in TakeAim CLL Study](https://biopharmsignal.com/news/CRIS/curis-consents-first-six-patients-in-takeaim-cll-study-45969449) — Source: Curis Inc - 2026-07-06 13:25 EST — AEMD — [Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules](https://biopharmsignal.com/news/AEMD/aethlon-medical-announces-pricing-of-4-0-million-follow-on-offering-priced-at-th-e3315678) — Source: Aethlon Medical - 2026-07-06 12:11 EST — ICCM — [IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer](https://biopharmsignal.com/news/ICCM/icecure-highlights-expanding-commercial-adoption-of-prosense-cryoablation-in-bra-814ddba1) — Source: IceCure Medical - 2026-07-03 11:30 EST — KURA — [Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/KURA/kura-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-32057cde) — Source: Kura Oncology - 2026-07-02 20:05 EST — OM — [Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/OM/outset-medical-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-21643aa5) — Source: Outset Medical - 2026-07-02 20:01 EST — IKT — [Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/IKT/inhibikase-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-56-d71ac313) — Source: Inhibikase Therapeutics ## Companies - [MASS](https://biopharmsignal.com/company/MASS) — 908 Devices - [ACXP](https://biopharmsignal.com/company/ACXP) — Acurx Pharmaceuticals - [AFIB](https://biopharmsignal.com/company/AFIB) — Acutus Medical - [AEMD](https://biopharmsignal.com/company/AEMD) — Aethlon Medical - [DRTS](https://biopharmsignal.com/company/DRTS) — Alpha Tau Medical - [ALVO](https://biopharmsignal.com/company/ALVO) — Alvotech - [AMGN](https://biopharmsignal.com/company/AMGN) — Amgen Inc. - [FOLD](https://biopharmsignal.com/company/FOLD) — Amicus Therapeutics - [ANPC](https://biopharmsignal.com/company/ANPC) — AnPac Bio-Medical Science - [APYX](https://biopharmsignal.com/company/APYX) — Apyx Medical - [ARDX](https://biopharmsignal.com/company/ARDX) — Ardelyx - [AZN](https://biopharmsignal.com/company/AZN) — AstraZeneca PLC - [RCEL](https://biopharmsignal.com/company/RCEL) — Avita Medical - [BCYC](https://biopharmsignal.com/company/BCYC) — Bicycle Therapeutics - [BCRX](https://biopharmsignal.com/company/BCRX) — BioCryst Pharmaceuticals - [BMEA](https://biopharmsignal.com/company/BMEA) — Biomea Fusion - [CCCC](https://biopharmsignal.com/company/CCCC) — C4 Therapeutics - [CDXI](https://biopharmsignal.com/company/CDXI) — Cardax Pharma - [CLSD](https://biopharmsignal.com/company/CLSD) — Clearside Biomedical - [CRVS](https://biopharmsignal.com/company/CRVS) — Corvus Pharmaceuticals - [CELZ](https://biopharmsignal.com/company/CELZ) — Creative Medical Technology Holdings - [CRIS](https://biopharmsignal.com/company/CRIS) — Curis Inc - [LLY](https://biopharmsignal.com/company/LLY) — Eli Lilly - [ENTA](https://biopharmsignal.com/company/ENTA) — Enanta Pharmaceuticals - [ESMC](https://biopharmsignal.com/company/ESMC) — Escalon Medical - [EPIX](https://biopharmsignal.com/company/EPIX) — ESSA Pharma - [EXEL](https://biopharmsignal.com/company/EXEL) — Exelixis - [FGEN](https://biopharmsignal.com/company/FGEN) — FibroGen - [FMS](https://biopharmsignal.com/company/FMS) — Fresenius Medical Care Ventures - [FULC](https://biopharmsignal.com/company/FULC) — Fulcrum Therapeutics - [GTHX](https://biopharmsignal.com/company/GTHX) — G1 Therapeutics - [GMED](https://biopharmsignal.com/company/GMED) — Globus Medical - [GSK](https://biopharmsignal.com/company/GSK) — GSK plc - [HSDT](https://biopharmsignal.com/company/HSDT) — Helius Medical Technologies - [ICCM](https://biopharmsignal.com/company/ICCM) — IceCure Medical - [ICUI](https://biopharmsignal.com/company/ICUI) — ICU Medical - [NARI](https://biopharmsignal.com/company/NARI) — Inari Medical - [IKT](https://biopharmsignal.com/company/IKT) — Inhibikase Therapeutics - [INVA](https://biopharmsignal.com/company/INVA) — Innoviva - [ITCI](https://biopharmsignal.com/company/ITCI) — Intra-Cellular Therapies - [IOVA](https://biopharmsignal.com/company/IOVA) — Iovance Biotherapeutics, Inc. - [JNJ](https://biopharmsignal.com/company/JNJ) — Johnson & Johnson - [DERM](https://biopharmsignal.com/company/DERM) — Journey Medical Corporation - [KALV](https://biopharmsignal.com/company/KALV) — KalVista Pharmaceuticals, Inc. - [KRMD](https://biopharmsignal.com/company/KRMD) — KORU Medical Systems - [KURA](https://biopharmsignal.com/company/KURA) — Kura Oncology - [KYMR](https://biopharmsignal.com/company/KYMR) — Kymera - [MNOV](https://biopharmsignal.com/company/MNOV) — MediciNova - [MMSI](https://biopharmsignal.com/company/MMSI) — Merit Medical - [MODD](https://biopharmsignal.com/company/MODD) — Modular Medical - [NMRD](https://biopharmsignal.com/company/NMRD) — Nemaura Medical - [NMTC](https://biopharmsignal.com/company/NMTC) — NeuroOne Medical Technologies - [NRIX](https://biopharmsignal.com/company/NRIX) — Nurix Therapeutics - [OCEA](https://biopharmsignal.com/company/OCEA) — Ocean Biomedical - [OCUP](https://biopharmsignal.com/company/OCUP) — Ocuphire - [OMER](https://biopharmsignal.com/company/OMER) — Omeros - [OM](https://biopharmsignal.com/company/OM) — Outset Medical - [PCRX](https://biopharmsignal.com/company/PCRX) — Pacira BioSciences - [MD](https://biopharmsignal.com/company/MD) — Pediatrix Medical Group, Inc. - [PMVP](https://biopharmsignal.com/company/PMVP) — PMV Pharmaceuticals - [QIPT](https://biopharmsignal.com/company/QIPT) — Quipt Home Medical - [RPID](https://biopharmsignal.com/company/RPID) — Rapid Micro Biosystems - [RMTI](https://biopharmsignal.com/company/RMTI) — Rockwell Medical - [SNY](https://biopharmsignal.com/company/SNY) — Sanofi - [ICU](https://biopharmsignal.com/company/ICU) — SeaStar Medical - [SEM](https://biopharmsignal.com/company/SEM) — Select Medical - [SWAV](https://biopharmsignal.com/company/SWAV) — Shockwave Medical - [SILK](https://biopharmsignal.com/company/SILK) — Silk Road Medical - [SNDX](https://biopharmsignal.com/company/SNDX) — Syndax Pharmaceuticals - [TLIS](https://biopharmsignal.com/company/TLIS) — Talis Biomedical Corp - [TSHA](https://biopharmsignal.com/company/TSHA) — Taysha Gene Therapies - [TNON](https://biopharmsignal.com/company/TNON) — Tenon Medical - [TERN](https://biopharmsignal.com/company/TERN) — Terns Pharmaceuticals - [TMCI](https://biopharmsignal.com/company/TMCI) — Treace Medical Concepts - [VTYX](https://biopharmsignal.com/company/VTYX) — Ventyx Biosciences, Inc. - [VRTX](https://biopharmsignal.com/company/VRTX) — Vertex Pharmaceuticals Incorporated - [VTRS](https://biopharmsignal.com/company/VTRS) — Viatris Inc. - [VANI](https://biopharmsignal.com/company/VANI) — Vivani Medical - [XFOR](https://biopharmsignal.com/company/XFOR) — X4 Pharmaceuticals - [XTNT](https://biopharmsignal.com/company/XTNT) — Xtant Medical - [ZNTL](https://biopharmsignal.com/company/ZNTL) — Zentalis